The decrease in mortality, morbidity were seen with trametinib for children with RASopathy-associated hypertrophic cardiomyopathy. HealthDay News — For children with severe hypertrophic cardiomyopathy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback